The
Greater Noida plant of HCIL will, however, continue with the operations of its
head office functions, India R&D Centre and spare parts operations
(including warehouse) for automobile, two-wheeler and power product
business.
Gaku
Nakanishi, President & CEO, Honda Cars India said, “Despite an uptick in
sales in the last three months, the current market conditions remain
unpredictable for the industry at large. The impact of COVID-19 has pressed us
to strengthen our constitution, and to achieve the same, HCIL has decided to
consolidate its manufacturing operations by making the Tapukara plant a unified
manufacturing base.
HCIL
continues to believe in the resilience of the Indian economy and hope for a
quicker recovery of the market. India is extremely important market in Honda’s
global strategy and HCIL is committed to bring its latest and advanced technology
models including electrified vehicles in future.”
With
resumption of operations after the COVID-19 led lockdown, HCIL successfully
ramped-up its daily production volume to pre-covid level from September 2020
and has been consistently witnessing monthly sales growth for the last three
months. HCIL sales showed good recovery in the festive period and the company
expects to sustain this sales momentum during the coming months.
HCIL’s
Tapukara plant is spread over 450 acres with an installed production capacity
of 1,80,000 units/annum and is an integrated manufacturing unit including all
functions of Forging, Press Shop, Powertrain shop, Weld shop, Paint shop,
Plastic Moulding, Engine assembly, Frame assembly, and Engine Testing facility.